California AG Bonta says case against Meta is about 'restitution and distortion,' not damages

Aug 18, 2026 - 21:40

0 0

California AG Bonta says case against Meta is about 'restitution and distortion,' not damages

Following opening arguments in the case against Meta, California Attorney General Bonta said the trial is not about extracting a massive payout.

What's Your Reaction?

Like 0

Dislike 0

Love 0

Funny 0

Angry 0

Sad 0

Wow 0

Related Posts

Business Insider analyzed federal student loan data for all 50 states, finding 42.3 million borrowers owed more than $1.72 trillion as of June 30, with an estimated average balance of $40,768 nationwide.

Business Insider analyzed federal student loan data for...

Oct 2, 2026 0 0

Treasury and the IRS have issued new guidance targeting Section 351 ETF conversions used by wealthy investors to defer capital gains taxes, saying some transactions that use an ETF as a conduit do not work under existing law.

Treasury and the IRS have issued new guidance targeting...

Oct 2, 2026 0 0

Trump says Europe has agreed to release a massive amount of diesel reserves, with the process starting immediately, as wars in Eastern Europe and the Middle East constrain global fuel supplies and lift diesel prices.

Trump says Europe has agreed to release a massive amoun...

Oct 2, 2026 0 0

South Korea is taking a cautious approach to the Alaska LNG project even as President Donald Trump says the two countries agreed to work on it as part of Seoul’s $200 billion U.S. investment package.

South Korea is taking a cautious approach to the Alaska...

Oct 2, 2026 0 0

Amazon is warning that widespread data center moratoriums in the US could hurt the country’s AI competitiveness for generations, while saying it will invest more than $1 billion over five years in communities where it operates data centers.

Amazon is warning that widespread data center moratoriu...

Oct 2, 2026 0 0

Novartis has agreed to pay up to $7.8 billion in a licensing deal with China-based Abogen Biosciences for global rights to an early-stage experimental autoimmune disease treatment and other RNA platform assets.

Novartis has agreed to pay up to $7.8 billion in a lice...

Oct 2, 2026 0 0